Earlier this year, Johnson & Johnson announced the first major regulatory approval of a vaccine developed by Janssen for the prevention of Ebola. Nikki Withers spoke with the Global Head of Vaccines, Johan Van Hoof, to discover what technologies were used and how they are now being leveraged to develop…
List view / Grid view
Innovative Medicines Initiative (IMI)
Filter the results
Marie Manley and co-authors from Sidley Austin explain the updates to regulations in the EU and UK in light of the COVID-19 coronavirus pandemic.
7 February 2013 | By Innovative Medicines Initiative (IMI)
Large pharmaceutical companies join forces with small and medium-sized enterprises (SMEs) and academia in an IMI-supported public private partnership (PPP) to enhance early drug discovery and so address the ever-increasing need for innovative therapeutics to tackle unmet medical needs...
Roche and the Innovative Medicines Initiative join forces to promote use of Nobel Prize-winning stem cell technology to enhance drug development
5 December 2012 | By Roche
Roche and the IMI launch StemBANCC...